Editorial
doi: 10.1056/NEJMe1714680.
Epub 2017 Dec 10.
A Milestone for CAR T Cells
Affiliations
- PMID: 29226781
- DOI: 10.1056/NEJMe1714680
Item in Clipboard
Editorial
A Milestone for CAR T Cells
N Engl J Med.
.
No abstract available
Comment on
-
Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas.N Engl J Med. 2017 Dec 28;377(26):2545-2554. doi: 10.1056/NEJMoa1708566. Epub 2017 Dec 10. N Engl J Med. 2017. PMID: 29226764 Free PMC article. Clinical Trial.
-
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma.N Engl J Med. 2017 Dec 28;377(26):2531-2544. doi: 10.1056/NEJMoa1707447. Epub 2017 Dec 10. N Engl J Med. 2017. PMID: 29226797 Free PMC article. Clinical Trial.
Similar articles
-
Functional design of chimeric T-cell antigen receptors for adoptive immunotherapy of cancer: architecture and outcomes.Anticancer Res. 2012 Jun;32(6):2377-83. Anticancer Res. 2012. PMID: 22641678 Review.
-
Manufacture of CAR-T cells in the body.Nat Biotechnol. 2017 Jun 7;35(6):520-521. doi: 10.1038/nbt.3898. Nat Biotechnol. 2017. PMID: 28591119 No abstract available.
-
Interleukin-armed chimeric antigen receptor-modified T cells for cancer immunotherapy.Gene Ther. 2018 Jun;25(3):192-197. doi: 10.1038/gt.2017.81. Epub 2017 Sep 21. Gene Ther. 2018. PMID: 28820501 Review.
-
[Research Progress on Chimeric Antigen Receptor T Cells-Review].Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017 Dec;25(6):1829-1832. doi: 10.7534/j.issn.1009-2137.2017.06.046. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017. PMID: 29262925 Review. Chinese.
-
[Prospect for chimeric antigen receptor-engineered T cell immunotherapy for solid tumors].Zhonghua Zhong Liu Za Zhi. 2018 Jul 23;40(7):490-492. doi: 10.3760/cma.j.issn.0253-3766.2018.07.002. Zhonghua Zhong Liu Za Zhi. 2018. PMID: 30060355 Chinese.
Cited by
-
Identification of early predictive biomarkers for severe cytokine release syndrome in pediatric patients with chimeric antigen receptor T-cell therapy.Front Immunol. 2024 Sep 12;15:1450173. doi: 10.3389/fimmu.2024.1450173. eCollection 2024. Front Immunol. 2024. PMID: 39328408 Free PMC article.
-
The landscape of mRNA nanomedicine.Nat Med. 2022 Nov;28(11):2273-2287. doi: 10.1038/s41591-022-02061-1. Epub 2022 Nov 10. Nat Med. 2022. PMID: 36357682 Review.
-
Engineering the next generation of cell-based therapeutics.Nat Rev Drug Discov. 2022 Sep;21(9):655-675. doi: 10.1038/s41573-022-00476-6. Epub 2022 May 30. Nat Rev Drug Discov. 2022. PMID: 35637318 Free PMC article. Review.
-
Treatment of acute kidney injury in cancer patients.Clin Kidney J. 2021 Dec 24;15(5):873-884. doi: 10.1093/ckj/sfab292. eCollection 2022 May. Clin Kidney J. 2021. PMID: 35498895 Free PMC article. Review.
-
Harnessing the Anti-Tumor Mediators in Mast Cells as a New Strategy for Adoptive Cell Transfer for Cancer.Front Oncol. 2022 Mar 31;12:830199. doi: 10.3389/fonc.2022.830199. eCollection 2022. Front Oncol. 2022. PMID: 35433433 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
